Verbatim response from Claude
Compounded Tirzepatide Availability
This is a rapidly changing situation, so here's the current landscape:
What Happened
The FDA removed tirzepatide (Zepbound/Mounjaro) from its shortage list in late 2024, which triggered a ban on most compounded versions. Many compounding pharmacies had to stop producing it.
Still Potentially Legitimate Options
503A Compounding Pharmacies (patient-specific prescriptions):
- May still compound for patients with documented allergies or specific clinical needs
- Requires a legitimate prescription and documented medical justification
Some Telehealth Platforms Still Navigating This:
- Hims & Hers - has been working through compliance issues
- LifeMD - adjusting offerings
- Henry - similar situation
Important Caveats
- The FDA has been actively enforcing against unapproved compounded versions
- Any current availability may change within weeks or months
- Verify any pharmacy is PCAB-accredited or an FDA-registered 503B facility
Honest Recommendation
Check with:
- Your doctor directly
- Cost Plus Drugs (costplusdrugs.com) for transparency
- Manufacturer savings programs for brand-name Zepbound
The situation is genuinely fluid - I'd verify current status directly with providers before committing.